| Accession |
PRJCA028385 |
| Title |
Efficacy of Cadonilimab and Anlotinib Combination in Treating Multiple Drug-Resistant Pulmonary Large Cell Neuroendocrine Carcinoma: Insights from a Case Report and Literature Review |
| Relevance |
Medical |
| Data types |
Genome sequencing
|
| Organisms |
Homo sapiens
|
| Description |
This study assesses the efficacy of different treatment approaches, such as the use of cadonilimab and anlotinib, by monitoring the patient's response through various cycles of treatment. This includes the use of computed tomography scans to evaluate treatment response. We believe that our study makes a significant contribution to the literature because the case report explores alternative treatment options for pulmonary large cell neuroendocrine carcinoma patients who have shown resistance to traditional programmed death 1 monoclonal antibodies and multiple chemotherapies. The use of cadonilimab and anlotinib in this context is highlighted, suggesting that this combination could be a potential treatment strategy. |
| Sample scope |
human |
| Release date |
2024-07-22 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| National Natural Science Foundation of China
|
|
82260498
|
|
| National Natural Science Foundation of China
|
|
82160471
|
|
| Quzhou City Qujiang District Life Oasis Public Welfare Service Center; Health Development Promotion Project - Cancer Research Project
|
|
BJHA-CRP-033
|
|
| Guangxi Medical and health key discipline construction project
|
|
-
|
|
| 2021 Guilin City Science Research and Technology Development Plan Project
|
|
20210227-7-9
|
|
| Beijing Xisike Clinical Oncology Research Foundation
|
|
Y-QL202101-0214
|
|
|
|
| Submitter |
Feng
Xue (xuefeng_doctor@126.com)
|
| Organization |
GuiLin Medical University |
| Submission date |
2024-07-22 |
